Skip to main content

Table 1 Patient, tumor, and treatment characteristics according to body mass index in 1099 patients with incident invasive breast cancer in the Malmö Diet and Cancer Study

From: Obesity and breast cancer prognosis: pre-diagnostic anthropometric measures in relation to patient, tumor, and treatment characteristics

 

Total

Healthy weight

Overweight

Obesity

N = 1099

N = 556

N = 384

N = 159

Age at diagnosis, median (IQR)

66.3 (61.2–72.8)

64.9 (59.9–70.5)

68.8 (62.8–73.9)

69.2 (63.3–76.2)

Menopausal status at diagnosis

 Premenopausal

65 (6.4%)

40 (7.7%)

19 (5.5%)

6 (4.0%)

 Postmenopausal

951 (93.6%)

478 (92.3%)

329 (94.5%)

144 (96.0%)

Histological grade according to Nottingham score

 Grade I, 3–5 p

269 (26.6%)

160 (31.2%)

76 (21.7%)

33 (22.4%)

 Grade II, 6–7 p

478 (47.3%)

239 (46.6%)

162 (46.3%)

77 (52.4%)

 Grade III, 8–9 p

263 (26.0%)

114 (22.2%)

112 (32.0%)

37 (25.2%)

Tumor size, mm

  < 10

178 (17.0%)

102 (19.0%)

57 (15.8%)

19 (12.7%)

 10–20

568 (54.3%)

296 (55.1%)

196 (54.4%)

76 (50.7%)

  > 20

301 (28.7%)

139 (25.9%)

107 (29.7%)

55 (36.7%)

Nodal status

 Negative

675 (68.3%)

366 (71.6%)

218 (64.9%)

91 (64.1%)

 Positive

314 (31.7%)

145 (28.4%)

118 (35.1%)

51 (35.9%)

Histological type

 Invasive ductal cancer

714 (69.8%)

353 (68.1%)

256 (71.3%)

105 (71.9%)

 Invasive lobular cancer

201 (19.6%)

110 (21.2%)

63 (17.5%)

28 (19.2%)

 Other

108 (10.6%)

55 (10.6%)

40 (11.1%)

13 (8.9%)

Estrogen receptor status

 Negative

97 (10.1%)

48 (9.9%)

36 (10.8%)

13 (9.3%)

 Positive

860 (89.9%)

436 (90.1%)

297 (89.2%)

127 (90.7%)

Surgical procedure

 Mastectomy

427 (42.1%)

225 (43.1%)

138 (39.9%)

64 (43.8%)

 Breast conserving surgery

587 (57.9%)

297 (56.9%)

208 (60.1%)

82 (56.2%)

Endocrine therapy, planned adjuvant

 No

453 (42.7%)

247 (45.8%)

142 (38.4%)

64 (42.1%)

 Yes

608 (57.3%)

292 (54.2%)

228 (61.6%)

88 (57.9%)

Chemotherapy, planned adjuvant

 No

844 (84.0%)

412 (82.7%)

305 (84.3%)

127 (87.6%)

 Yes

161 (16.0%)

86 (17.3%)

57 (15.7%)

18 (12.4%)

Radiotherapy, planned adjuvant

 No

397 (39.4%)

199 (40.0%)

139 (38.2%)

59 (40.7%)

 Yes

610 (60.6%)

299 (60.0%)

225 (61.8%)

86 (59.3%)

Socioeconomic position

 Low

302 (28.3%)

101 (18.8%)

132 (35.2%)

69 (44.8%)

 Low middle

64 (6.0%)

28 (5.2%)

19 (5.1%)

17 (11.0%)

 High middle

346 (32.4%)

193 (35.9%)

119 (31.7%)

34 (22.1%)

 High

355 (33.3%)

216 (40.1%)

105 (28.0%)

34 (22.1%)

Do you smoke?

 Yes, I smoke regularly

270 (24.6%)

165 (29.7%)

76 (19.8%)

29 (18.2%)

 Yes, I smoke occasionally

35 (3.2%)

21 (3.8%)

10 (2.6%)

4 (2.5%)

 No, I have stopped smoking

333 (30.3%)

161 (29.0%)

122 (31.8%)

50 (31.4%)

 No, I have never smoked

461 (41.9%)

209 (37.6%)

176 (45.8%)

76 (47.8%)

  1. aIQR Interquartile range